Vaccines

26 Sep 2007 immatics launches Phase 2 study on cancer vaccine IMA901
26 Sep 2007 VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine
26 Sep 2007 Twinstrand Therapeutics Inc. Files IND Application For Immunogen in Ricin Antidote Study
22 Sep 2007 Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate
20 Sep 2007 FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
20 Sep 2007 Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
19 Sep 2007 Iomai Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study
19 Sep 2007 Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at Low Dosage
12 Sep 2007 Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
12 Sep 2007 Oxford BioMedica Reaches First Milestone in TroVax(T) Collaboration with Sanofi-Aventis
12 Sep 2007 Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin® for Treatment of Multiple Sclerosis
11 Sep 2007 TapImmune Inc. Announces Initiation of Testing on Novel Cancer Vaccine
11 Sep 2007 GenVec to Develop New Malaria Vaccine for the U.S Military
11 Sep 2007 Nventa initiates HspE7 Phase 1 Cervical Dysplasia Trial
08 Sep 2007 MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
07 Sep 2007 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
07 Sep 2007 Introgen's p53 Immunotherapy Drug Candidate to Advance Into Second Phase 2 Clinical Trial in Small Cell Lung Cancer With National Cancer Institute
06 Sep 2007 Merck: Stimuvax(R) Therapeutic Cancer Vaccine - Phase II Data Highlight Three-Year Survival Results for Lung Cancer Patients
06 Sep 2007 Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
04 Sep 2007 FDA Approves ACAM2000(TM) Vaccine for Protection against Smallpox
31 Aug 2007 Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine
29 Aug 2007 Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
28 Aug 2007 Immutep Announces That ImmuFact(R) IMP321 Has Entered a Phase I Lymphodepletion Therapeutic Vaccine Trial in Metastatic Melanoma
24 Aug 2007 Encouraging Phase II data on HIV vaccine utilizing GenVec technologies presented at Seattle AIDS conference
23 Aug 2007 Achievement in the Development of Hepatitis C Virus Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top